Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses

No abstract is available for this paper.

• Publication year

  2012

• Venue

  British Journal of Psychiatry

• Publication date

  2012-02-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1192/bjp.bp.111.096594PMID 22297588
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.

  2016cited by this paper
• Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder

  2015cited by this paper
• British guideline on the management of asthma.

  2014cited by this paper
• Chlorpromazine versus placebo for schizophrenia.

  2014cited by this paper
• Haloperidol versus placebo for schizophrenia.

  2013cited by this paper
• Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.

  2013cited by this paper
• Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.

  2012cited by this paper
• Antimicrobial prophylaxis for colorectal surgery

  2012cited by this paper
• Thrombolysis in acute ischaemic stroke.

  2012cited by this paper
• Maintenance treatment with antipsychotic drugs for schizophrenia.

  2012cited by this paper
• Bayesian Meta‐Analysis

  2012cited by this paper
• Ribavirin plus interferon versus interferon for chronic hepatitis C.

  2010cited by this paper
• Ribavirin plus interferon versus interferon for chronic hepatitis C.

  2010cited by this paper
• Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials

  2010cited by this paper
• Measures of efficiency in healthcare: QALMs about QALYs?

  2010cited by this paper
• WITHDRAWN: Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease.

  2010cited by this paper
• Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis

  2010cited by this paper
• Pharmacological interventions for the prevention of relapse in bipolar disorder: a systematic review of controlled trials

  2009cited by this paper
• Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

  2009cited by this paper
• Effects of Intensive Glucose Lowering in Type 2 Diabetes

  2009cited by this paper
• Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

  2009cited by this paper
• Thrombolysis for acute ischaemic stroke.

  2009cited by this paper
• The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

  2009cited by this paper
• Antibiotics versus placebo or watchful waiting for acute otitis media: a meta-analysis of randomized controlled trials.

  2009cited by this paper
• How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials

  2009cited by this paper
• Magnitude of benefit of adjuvant chemotherapy for non-small cell lung cancer: meta-analysis of randomized clinical trials.

  2009cited by this paper
• AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews.

  2009cited by this paper
• Ribavirin monotherapy for chronic hepatitis C.

  2009cited by this paper
• Pegylated interferon plus ribavirin versus non‐pegylated interferon plus ribavirin for chronic hepatitis C

  2009cited by this paper
• Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: a meta-analysis of randomized controlled trials.

  2009cited by this paper
• Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: A systematic review and meta-analysis

  2008cited by this paper
• Meta-analysis: Effects of Adding Salmeterol to Inhaled Corticosteroids on Serious Asthma-Related Events

  2008cited by this paper
• Anticoagulants for acute ischaemic stroke.

  2008cited by this paper
• Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials.

  2008cited by this paper
• Effects of Intensive Glucose Lowering in Type 2 Diabetes The Action to Control Cardiovascular Risk in Diabetes Study Group

  2008cited by this paper
• Selective publication of antidepressant trials and its influence on apparent efficacy.

  2008cited by this paper
• Effects of intensive glucose lowering in type 2 diabetes.

  2008cited by this paper
• BTS guideline for emergency oxygen use in adult patients

  2008cited by this paper
• Statin therapy in stroke prevention: a meta-analysis involving 121,000 patients.

  2008cited by this paper
• Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and Presentation

  2008cited by this paper
• Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta-analysis of individual patient data.

  2008cited by this paper
• Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD).

  2008cited by this paper
• Antiplatelet therapy for acute ischaemic stroke.

  2008cited by this paper
• Antibiotics for acute otitis media: a meta-analysis with individual patient dataRovers MM, Glasziou P, Appelman CL, et al (Univ Med Centre Utrecht, The Netherlands; Univ of Oxford, England; Univ of Texas, Galveston; et al) Lancet 368:1429–1435, 2006§

  2008cited by this paper
• Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

  2008cited by this paper
• British Guideline on the Management of Asthma

  2008cited by this paper
• Anticonvulsants in Migraine Prophylaxis: A Cochrane Review

  2008cited by this paper
• Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials

  2008cited by this paper
• Fluticasone versus placebo for chronic asthma in adults and children.

  2008cited by this paper
• Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration

  2008cited by this paper
• Meta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressants.

  2008cited by this paper
• Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline

  2008cited by this paper
• Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis.

  2008cited by this paper
• Medical treatments in the short term management of reflux oesophagitis.

  2007cited by this paper
• Association between unreported outcomes and effect size estimates in Cochrane meta-analyses.

  2007cited by this paper
• Inoperable brain metastases from non-small cell lung cancer: what part does whole brain radiotherapy play in standard treatment?

  2007cited by this paper
• Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials.

  2007cited by this paper
• Paroxetine versus placebo and other agents for depressive disorders: a systematic review and meta-analysis.

  2007cited by this paper
• A Meta-analysis of the Effects of Presenting Treatment Benefits in Different Formats

  2007cited by this paper
• Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials.

  2007cited by this paper
• Tiotropium for the treatment of stable chronic obstructive pulmonary disease: a systematic review with meta-analysis.

  2007cited by this paper
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

  2007cited by this paper
• Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis.

  2007cited by this paper
• Efficacy and safety of 1,000mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms

  2007cited by this paper
• Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials

  2007cited by this paper
• Meglitinide analogues for type 2 diabetes mellitus.

  2007cited by this paper
• [Guidelines for the diagnosis and therapy of COPD issued by Deutsche Atemwegsliga and Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin].

  2007cited by this paper
• Defining ‘Response’ in Antipsychotic Drug Trials: Recommendations for the Use of Scale-Derived Cutoffs

  2007cited by this paper
• Magnitude of effect of lithium in short-term efficacy studies of moderate to severe manic episode.

  2007cited by this paper
• Inhaled corticosteroids for stable chronic obstructive pulmonary disease.

  2007cited by this paper
• Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents—meta-analysis and meta-regression analysis

  2007cited by this paper
• Efficacy and safety of cholesterol-lowering treatment: prospective metaanalysis of data from 90 056 participants in 14 randomised trials of statins

  2007cited by this paper
• Tissue ACE Inhibitors for Secondary Prevention of Cardiovascular Disease in Patients With Preserved Left Ventricular Function: A Pooled Meta-analysis of Randomized Placebo-controlled Trials

  2007cited by this paper
• A systematic review and economic evaluation of statins for the prevention of coronary events.

  2007cited by this paper
• Meta-Analysis: Effect of Long-Acting -Agonists on Severe Asthma Exacerbations and Asthma-Related Deaths

  2006cited by this paper
• Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.

  2006cited by this paper
• Antibiotics for acute otitis media: a meta-analysis with individual patient data.

  2006cited by this paper
• Meta-analysis: Anticholinergics, but not β-agonists, reduce severe exacerbations and respiratory mortality in COPD

  2006cited by this paper
• Review of 'Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths.' Salpeter SR, Buckley NS, Ormiston TM, Salpeter EE. Ann Intern Med 2006;144:904-12.

  2006cited by this paper
• Aspirin for the Primary Prevention of Cardiovascular Events in Women and Men: A Sex-Specific Meta-Analysis of Randomized Controlled Trials

  2006cited by this paper
• Tiotropium for stable chronic obstructive pulmonary disease: a meta-analysis

  2006cited by this paper
• Efficacy and Safety of Inhaled Corticosteroids in Patients With COPD: A Systematic Review and Meta-Analysis of Health Outcomes

  2006cited by this paper
• The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol.

  2006cited by this paper
• Diuretics for heart failure.

  2006cited by this paper
• Cholinesterase inhibitors for Alzheimer's disease.

  2006cited by this paper
• Addition of salmeterol to usual asthma pharmacotherapy may increase respiratory related deaths or life threatening experiences

  2006cited by this paper
• Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease.

  2005cited by this paper
• A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia.

  2005cited by this paper
• Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis

  2005cited by this paper
• Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.

  2005cited by this paper
• Adalimumab for treating rheumatoid arthritis.

  2005cited by this paper
• Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.

  2005cited by this paper
• Efficacy and Safety of Second-Generation Antidepressants in the Treatment of Major Depressive Disorder

  2005cited by this paper
• Metformin monotherapy for type 2 diabetes mellitus.

  2005cited by this paper
• The effect of treatment with omalizumab, an anti‐IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma

  2005cited by this paper
• Short-term low-dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheumatoid arthritis.

  2005cited by this paper
• Alpha-glucosidase inhibitors for type 2 diabetes mellitus.

  2005cited by this paper
• Headaches and the Treatment of Blood Pressure: Results From a Meta-Analysis of 94 Randomized Placebo-Controlled Trials With 24 000 Participants

  2005cited by this paper
• Prognostic benefit of beta-blockers in patients not receiving ACE-Inhibitors.

  2005cited by this paper
• Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials

  2005cited by this paper

• Integrating Physical Healthcare into Psychiatry for Severe Mental Illness: A Narrative Review and Position Statementfrom the ECNP PAN-Health Group

  2026cites this paper
• Antipsychotika abseits der Dopamin-D2-Blockade – Xanomelin-Trospium als Hoffnungsträger?

  2025cites this paper
• Empowering clinicians and patients in antipsychotic dose reduction for schizophrenia: the role of online tools

  2025cites this paper
• PEAChY-O: Pharmacological Emergency Management of Agitation in Children and Young People: A Randomized Controlled Trial of Oral Medication.

  2025cites this paper
• Medical management of ADHD in adults: part 1

  2025cites this paper
• Factors associated with fluoxetine adherence among outpatients with common mental disorders in Western Kenya

  2025cites this paper
• Drug safety and pharmacovigilance in psychopharmacology

  2025cites this paper
• Efficacy of acupuncture versus sham acupuncture on generalized anxiety disorder: a meta-analysis of randomized controlled trials

  2025cites this paper
• Disorder at the Synapse: How the Active Inference Framework Unifies Competing Perspectives on Depression

  2025cites this paper
• Transforming the evidence landscape in mental health with platform trials

  2025cites this paper
• Impact of dualism on the perception of treatability in psychiatry

  2025cites this paper
• A Re-Appraisal of Three Network Meta-Analyses to Explain the Discrepancy in Findings for the Efficacy of Fluoxetine for the Treatment of Depression in Children and Adolescents

  2025cites this paper
• [Building precision psychiatry: why and how?]

  2025cites this paper
• The Brain-Gut-Microbiota Axis in Depression: Medical Progress

  2025cites this paper
• Understanding what Drives Efficacious CBT-I Interventions: Insights from a Circadian-Enriched Digital CBT-I Trial in University Students.

  2025cites this paper
• Acceptance and commitment therapy among caregivers of people with cancer: a systematic review and meta-analysis

  2025cites this paper
• A systematic review and synthesis of 489 studies investigating treatments for negative symptoms in the schizophrenia spectrum: Trial designs, demographics and clinical characteristics.

  2025cites this paper
• Suicide prediction, prevention, and the blame culture: A narrative review based on trends in mortality rates

  2025cites this paper
• Should clozapine be offered as a second-line antipsychotic?

  2025cites this paper
• Die Geschichte des medizinischen Modells der Depression – mit (fast) all ihren Vor- und Nachteilen

  2025cites this paper
• Patterns and predictors of 12-month treatment of common anxiety, mood, and substance use disorders in the World Mental Health (WMH) surveys: treatment in the context of perceived need

  2025cites this paper
• Near, far, wherever you are: phenotype-related variation in pharmacogenomic effect sizes across the psychiatric drug literature

  2025cites this paper
• Psychotic symptoms during pharmacological treatment of ADHD: clinical considerations and research needs.

  2025cites this paper
• Underused treatments in psychiatry: electroconvulsive therapy, clozapine and lithium

  2025cites this paper
• Antipsykotika har god effekt ved psykoselidelser

  2025cites this paper
• Psychiatric Medications Procurement at Primary Health Centers (PHCs) in Tumkur: Insights from an Effectiveness Implementation Hybrid Randomized Controlled Trial on Mental Health Tele-mentoring of Primary Care Doctors (PCDs).

  2025cites this paper
• Do antipsychotics work in people with schizophrenia? A review of outcomes and effect sizes

  2025influential citation
• The clinical pathway in ADMiRE, Ireland’s first public specialist service for children and adolescents with attention deficit hyperactivity disorder

  2024cites this paper
• History, ‘nowtime’ (jetztzeit) and dialectical images: introduction to Walter Benjamin for psychiatry (I)

  2024cites this paper
• Finding Joy in Our Work

  2024cites this paper
• Simulation investigations of thermodynamic properties for silica nanoparticles and voxelotor docking effect with hemoglobin for sickle cell disease

  2024cites this paper
• Ireland’s Mental Health Bill 2024: progress, problems and Procrustean perils

  2024cites this paper
• A mindfulness- and relaxation-based nature intervention improves mood in depressed patients in psychosomatic rehabilitation: Results from the GREENCARE non-randomized controlled clinical trial.

  2024cites this paper
• Deprescribing antidepressants for depression – what is the evidence for and against?

  2024cites this paper
• A review of the WHO strategy on traditional, complementary, and integrative medicine from the perspective of academic consortia for integrative medicine and health

  2024cites this paper
• Repurposing General Anesthetic Drugs to Treat Depression: A New Frontier for Anesthesiologists in Neuropsychiatric Care.

  2024cites this paper
• Biomarkers for Psychosis: Are We There Yet? Umbrella Review of 1478 Biomarkers

  2024cites this paper
• Nurturing the Mind from Within: Exploring the Role of Gut–Microbiota–Brain Axis in Postpartum Depression

  2024cites this paper
• Oxcarbazepine for the treatment of bipolar and depressive disorders in the outpatient setting: A retrospective chart review

  2024cites this paper
• Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for Depression

  2024cites this paper
• Pharmacists' Knowledge, Attitudes And Beliefs About Attention Deficit And Hyperactivity Disorder And Medical Treatment

  2024cites this paper
• Hype or hope? High placebo response in major depression treatment with ketamine and esketamine: a systematic review and meta-analysis

  2024cites this paper
• ESCAP endorses the inclusion of methylphenidate in the WHO model lists of essential medicines and in the Union list of critical medicines

  2024cites this paper
• Estimating the smallest worthwhile difference of antidepressants: a cross-sectional survey

  2024cites this paper
• Effects of Lacticaseibacillus rhamnosus HN001 on Happiness and Mental Well-Being: Findings from a Randomized Controlled Trial

  2024influential citation
• A comparison of clinical characteristics and course predictors in early‐ and childhood‐onset schizophrenia

  2024cites this paper
• Ten principles of good psychotropic drug prescribing

  2024cites this paper
• Antipsychotic Drugs: A Concise Review of History, Classification, Indications, Mechanism, Efficacy, Side Effects, Dosing, and Clinical Application.

  2024cites this paper
• The place of long-acting injectable antipsychotics in the treatment of schizophrenia

  2023cites this paper
• The experience of 'treatment-resistant' depression: A qualitative meta-synthesis.

  2023cites this paper
• Cyberbully victimization and its association with residual depressive symptoms among clinically stable adolescents with psychiatric disorders during the COVID-19 pandemic: A perspective from network analysis

  2023cites this paper
• The Future of Child and Adolescent Clinical Psychopharmacology: A Systematic Review of Phase 2, 3, or 4 Randomized Controlled Trials of Pharmacologic Agents Without Regulatory Approval or for Unapproved Indications.

  2023cites this paper
• The biological paradigm of psychosis in crisis: A Kuhnian analysis.

  2023cites this paper
• PUBLIC MENTAL HEALTH: AN AGENDA FOR ACTION.

  2023cites this paper
• The role of gut microbiota in the pathogenesis and treatment of postpartum depression

  2023cites this paper
• Acceptance and Commitment Therapy Among Informal Caregivers of People With Chronic Health Conditions

  2023cites this paper
• Facts and myths about the use of lithium for bipolar disorder in routine clinical practice: an expert consensus paper

  2023cites this paper
• Attitudes of South Australian psychiatrists towards attention deficit hyperactivity disorder in adults

  2023cites this paper
• Conflict and antagonism within global psychiatry: A discourse analysis of organisational responses to the UN reports on rights-based approaches in mental health.

  2023cites this paper
• Does Slow and Steady Win the Race? Rates of Antipsychotic Discontinuation, Antipsychotic Dose, and Risk of Psychotic Relapse

  2023cites this paper
• Multi-level protection of rights: India's Mental Healthcare Act, 2017 and the United Nations' Convention on the Rights of Persons with Disabilities (Articles 12 and 14).

  2023cites this paper
• Gut Microbiota in Anxiety and Depression: Unveiling the Relationships and Management Options

  2023cites this paper
• Sollten wir bei der Mehrzahl der Menschen mit einer psychotischen Erkrankung eine langfristige antipsychotische Rezidivprophylaxe anstreben? – Kontra

  2023cites this paper
• Fast tracking informative clinical trials: lessons for mental health

  2023cites this paper
• Psychological treatment outcomes for outpatients in a clinical context

  2023cites this paper
• WHO Model Lists of Essential Medicines: methylphenidate for ADHD in children and adolescents.

  2023cites this paper
• Time for united action on depression: a Lancet-World Psychiatric Association Commission.

  2022cites this paper
• Effects of Combing Group Executive Functioning and Online Parent Training on School-Aged Children With ADHD: A Randomized Controlled Trial

  2022cites this paper
• Initiating Antidepressant Medication: What is the Most Important Factor?

  2022cites this paper
• Prospects for improved prevention and treatment of neuropsychiatric disorders: Neuroscience Applied

  2022cites this paper
• The efficacy of psychotherapies and pharmacotherapies for mental disorders in adults: an umbrella review and meta‐analytic evaluation of recent meta‐analyses

  2022cites this paper
• What is the evidence for antipsychotic medication and alternative psychosocial interventions for people with acute, non-affective psychosis?

  2022cites this paper
• TEMPORARY REMOVAL: Effects of Flibanserin on Subdomain Scores of the Female Sexual Function Index in Women With Hypoactive Sexual Desire Disorder.

  2022cites this paper
• Mindfulness Meditation Interventions for Long COVID: Biobehavioral Gene Expression and Neuroimmune Functioning

  2022cites this paper
• Response to Commentary by Spielmans

  2022cites this paper
• Psychiatric services, mental health law, & human rights

  2022cites this paper
• Psychiatric diagnosis and treatment in the 21st century: paradigm shifts versus incremental integration

  2022cites this paper
• Psychiatry and/or recovery: a critical analysis

  2022cites this paper
• Timing of antipsychotics and benzodiazepine initiation during a first episode of psychosis impacts clinical outcomes: Electronic health record cohort study

  2022cites this paper
• Chronic Use of Antipsychotics in Schizophrenia: Are We Asking the Right Question?

  2022cites this paper
• Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review

  2022cites this paper
• Symptomatic versus disease‐modifying effects of psychiatric drugs

  2022cites this paper
• University students with attention deficit hyperactivity disorder (ADHD): a consensus statement from the UK Adult ADHD Network (UKAAN)

  2022cites this paper
• The Microbiota–Gut–Brain Axis in Depression: The Potential Pathophysiological Mechanisms and Microbiota Combined Antidepression Effect

  2022cites this paper
• Recent advances in psychoradiology

  2022cites this paper
• Psychiatry is the flagship of personalized and precision medicine: proposing an epistemic horizon to biological psychiatry

  2022cites this paper
• Main Debates on the Management of Mental Illness: 1990-2020. A Narrative Review

  2022influential citation
• Should We Use Expired Drugs When Necessary?

  2021cites this paper
• A Neurodevelopment Approach for a Transitional Model of Early Onset Schizophrenia

  2021influential citation
• The World Federation of ADHD International Consensus Statement: 208 Evidence-based Conclusions about the Disorder.

  2021cites this paper
• Zinc as an adjunct to antidepressant medication: a meta-analysis with subgroup analysis for different levels of treatment response to antidepressants

  2021cites this paper
• Psychotropic medicine beliefs, side effects and adherence in schizophrenia: a patient–caregiver dyad perspective

  2021cites this paper
• Cognitive Go/No-Go decision-making criteria in Alzheimer's disease drug development.

  2021cites this paper
• Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countries.

  2021cites this paper
• More treatment but no less depression: The treatment-prevalence paradox.

  2021cites this paper
• Side-effect monitoring of continuing LAI antipsychotic medication in UK adult mental health services

  2021cites this paper
• Effect of necessity‐concern framework and polypharmacy on treatment adherence in psychiatric patients. Comparing an Argentinian with a Spanish sample

  2021cites this paper
• From the Second Half of the Twentieth Century to the Early Twenty-First: The Psychopharmacologic Era

  2021cites this paper
• Editorial: The Long-term Impact of Attention-Deficit/Hyperactivity Disorder: Lessons From the Past and Directions for the Future.

  2021cites this paper
• Psychiatry is essential for now but might eventually disappear (although this is unlikely to happen any time soon)

  2021cites this paper